MP15-15 WHO ARE THE PATIENTS WHO BENEFIT THE MOST FROM EXTENDED PELVIC LYMPH NODE DISSECTION IN LOCALIZED PROSTATE CANCER? IDENTIFICATION OF THE OPTIMAL CANDIDATES TO BE INCLUDED IN A RANDOMIZED CONTROLLED TRIAL
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.